1. Home
  2. OCGN vs HSHP Comparison

OCGN vs HSHP Comparison

Compare OCGN & HSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • HSHP
  • Stock Information
  • Founded
  • OCGN 2013
  • HSHP 2021
  • Country
  • OCGN United States
  • HSHP Bermuda
  • Employees
  • OCGN N/A
  • HSHP N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • HSHP
  • Sector
  • OCGN Health Care
  • HSHP
  • Exchange
  • OCGN Nasdaq
  • HSHP Nasdaq
  • Market Cap
  • OCGN 321.7M
  • HSHP 268.6M
  • IPO Year
  • OCGN N/A
  • HSHP 2023
  • Fundamental
  • Price
  • OCGN $1.79
  • HSHP $7.94
  • Analyst Decision
  • OCGN Strong Buy
  • HSHP
  • Analyst Count
  • OCGN 3
  • HSHP 0
  • Target Price
  • OCGN $6.00
  • HSHP N/A
  • AVG Volume (30 Days)
  • OCGN 7.9M
  • HSHP 185.5K
  • Earning Date
  • OCGN 11-07-2025
  • HSHP 11-20-2025
  • Dividend Yield
  • OCGN N/A
  • HSHP 5.67%
  • EPS Growth
  • OCGN N/A
  • HSHP N/A
  • EPS
  • OCGN N/A
  • HSHP 0.14
  • Revenue
  • OCGN $4,754,000.00
  • HSHP $120,680,000.00
  • Revenue This Year
  • OCGN N/A
  • HSHP $7.72
  • Revenue Next Year
  • OCGN N/A
  • HSHP $27.02
  • P/E Ratio
  • OCGN N/A
  • HSHP $58.37
  • Revenue Growth
  • OCGN N/A
  • HSHP 44.77
  • 52 Week Low
  • OCGN $0.52
  • HSHP $4.29
  • 52 Week High
  • OCGN $1.90
  • HSHP $8.95
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 70.01
  • HSHP 41.24
  • Support Level
  • OCGN $1.31
  • HSHP $7.93
  • Resistance Level
  • OCGN $1.85
  • HSHP $8.39
  • Average True Range (ATR)
  • OCGN 0.14
  • HSHP 0.17
  • MACD
  • OCGN 0.02
  • HSHP -0.12
  • Stochastic Oscillator
  • OCGN 78.81
  • HSHP 2.94

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

Share on Social Networks: